Italy blocks exports of AstraZeneca vaccine doses to Australia

AstraZeneca, which manufactures its anti-Covid vaccine at sites in Belgium and the Netherlands, has a bottling and packaging plant in Italy.


Text by: RFI Follow

2 min

Italy blocks the export of 250,000 doses of AstraZeneca vaccine to Australia.

The Swedish laboratory has a bottling plant in Italy.

This is the first time that the European regulation on vaccine exports has been applied.

Europe had threatened AstraZeneca on several occasions following its announcements of delivery delays and it is carrying out its threats.

But it is more broadly the manifestation of a will of the European Union to keep the doses for Europeans.


Read more

With our correspondent in Brussels,  

Pierre Benazet

It was the Italian government that notified AstraZeneca of the ban on exports to Australia.

In fact, its decision was taken in agreement with the European Commission.

The export control mechanism specifies that it is indeed the States which decide, but "in 

accordance with the opinion of the Commission 


It's a new twist in the


between the European Commission and AstraZeneca, but in fact the Anglo-Swedish laboratory is almost by chance the first to find itself caught in the net.

Any export within the framework of a commercial contract must be submitted to customs clearance.

Italy justifies its decision by the

shortage of vaccines

in the European Union.

It would therefore seem that this control mechanism is in the process of being transformed into a mechanism for limiting exports at a time when Commissioner Thierry Breton, in charge of the Internal Market, now asserts that by the end of the summer the EU should be able to offer vaccination to all European citizens, well above the current target of 70%.

To read also: The European Union publishes its contract with the AstraZeneca laboratory


Receive all international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application


  • Italy

  • Vaccines

  • Coronavirus

On the same subject

France: AstraZeneca vaccine now open to 65-75 year olds


The side effects of the AstraZeneca vaccine do not call into question its effectiveness

International guest

AstraZeneca vaccine: "the ground must be prepared for new vaccines against variants"